infective%20endocarditis
INFECTIVE ENDOCARDITIS
Infective endocarditis is microbial infection of the endovascular structures of the heart.
It often presents in an occult fashion and early diagnosis depends on a high index of clinical suspicion especially in patients with congenital heart disease, prosthetic valves or previous infective endocarditis.
The established diagnosis of infective endocarditis is demonstrated by a positive blood culture and involvement of the endocardium detected during sepsis or systemic infection. It may also be established if there is involvement of the endocardium detected during sepsis or systemic infection but blood culture is negative.

Surgical Intervention

Principles of Surgical Treatment

  • Combined medical & surgical therapy for IE can decrease mortality among patients who have CHF, perivalvular invasive disease, or uncontrolled infection despite maximal antimicrobial therapy
  • The decision to perform surgery & its timing is dependent upon the cardiac & systemic complications caused by the infection, the microorganism’s virulence & the response to antimicrobial therapy
    • The optimal time to perform surgery is before severe hemodynamic disability or spread of the infection to perivalvular tissue occurs
  • CHF is the strongest indication for surgery in IE

Surgery should be considered in the following:

  • NVE patients w/ acute aortic or mitral regurgitation & CHF
  • Evidence of perivalvular extension
  • Persistent infection after 7-10 days of adequate antimicrobial therapy
  • Relapsing infection ie recurrence of bacteremia following a complete antibiotic course & subsequently negative BCs w/ no known source of infection
  • Infection w/ microorganisms that have poor response to antibiotic therapy (eg fungi, Brucella sp, Coxiella sp, Staphylococcus lugdunensis, Enterococcus sp w/ high-level resistance to Gentamicin, gram-negative organisms)
    • Left-sided IE caused by S aureus, fungal, or highly resistant organisms
  • NVE patients w/ mobile vegetation >10 mm before or during the 1st wk of antibiotic therapy
  • Recurrent emboli despite appropriate antibiotic therapy
  • Obstructive or persistent vegetations
  • Early PVE
  • Hemodynamically significant prosthetic valve
  • IE complicated by annular or aortic abscess, destructive penetrating lesion, or heart block
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 05 Dec 2017

Results of a study conducted by the Chinese University of Hong Kong (CUHK) revealed that patients who recovered from hepatitis B virus (HBV) infection are still at risk for hepatocellular carcinoma (HCC). 

30 Mar 2018
A US study suggests that expanding HIV screening to reduce undiagnosed infections and increasing access to care and treatment to achieve viral suppression are important to lessen HIV transmission. It is also imperative that prevention methods, such as condoms and pre-exposure prophylaxis, be easily accessed, particularly among young men who have sex with men (MSM) and MSM of colour.
Saras Ramiya, 5 days ago
The National Institutes of Health (NIH) and International Medical University (IMU) strengthens their research collaboration with the recent signing of a Memorandum of Understanding (MoU).
27 Jan 2018
In patients with chronic hepatitis B virus (HBV) infection, tenofovir alafenamide (TAF) shows comparable 96-week efficacy and improved renal and bone safety with tenofovir disoproxil fumarate (TDF), a recent study has shown.